PHO-COG-FALLON-ANBL00B1; Neuroblastoma Biology Studies

Primary Investigator
S

Sandeep Batra, MD

Primary Investigator

Administratively Closed
30 years or below
All
Phase N/A
3 Locations

Brief description of study

This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.

Detailed description of study

This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Neuroblastoma
  • Age: 30 years or below
  • Gender: All

Inclusion Criteria
Newly diagnosed with suspected neuroblastoma, suspected ganglionneuroblastoma
Exclusion Criteria
Patients with relapsed neuroblastoma who ere not enrolled on ANBL00B1 at original diagnosis
Additional Information:
Participants will not be paid for their participation.

Updated on 10 Nov 2025. Study ID: PHO-COG-FALLON-ANBL00B1,1011003226, NCT00904241

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the Study Team